Literature DB >> 15176177

Health technology assessment in four countries: response from political science.

David Chinitz1.   

Abstract

Four studies, each on health technology assessment (HTA) in a different country, are presented in this volume. Conveying differing levels of sensitivity to political aspects of HTA, their storylines are similar in terms of the importance of the institutional structures that produce HTA and mediate its influence on health policy decision making. Regarding the internal politics of HTA, the latter appears to have developed in a relatively depoliticized environment, supported by a dense and varied web of institutional sites for funding, production, and consumption of HTA, buffered from the capricious impacts of electoral politics. Regarding external politics, HTA in all the countries began with relatively politically innocuous studies of technologies recognized to be of major import to national health systems or researcher-initiated studies. However, with increased focus in health systems on explicit determination of health benefits baskets, the role of HTA has become more high profile. This means that political accountability for the entire HTA process will increase. The implication is that future management of HTA programs will require self-conscious attention to the building of institutions capable of handling the delicate process of integrating science and politics in health policy.

Mesh:

Year:  2004        PMID: 15176177     DOI: 10.1017/s0266462304000789

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

1.  Engaging the public in priority-setting for health technology assessment: findings from a citizens' jury.

Authors:  Devidas Menon; Tania Stafinski
Journal:  Health Expect       Date:  2008-09       Impact factor: 3.377

2.  Integrating evidence on patient preferences in healthcare policy decisions: protocol of the patient-VIP study.

Authors:  Carmen D Dirksen; Cecile Ma Utens; Manuela A Joore; Teus A van Barneveld; Bert Boer; Dunja Hh Dreesens; Hans van Laarhoven; Cees Smit; Anne M Stiggelbout; Trudy van der Weijden
Journal:  Implement Sci       Date:  2013-06-10       Impact factor: 7.327

3.  Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine.

Authors:  Wolf H Rogowski; Susanne C Hartz; Jürgen H John
Journal:  BMC Health Serv Res       Date:  2008-09-24       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.